TR202102255A2 - URINE ANALYSIS KIT AND METHOD OF USE - Google Patents

URINE ANALYSIS KIT AND METHOD OF USE

Info

Publication number
TR202102255A2
TR202102255A2 TR2021/002255A TR202102255A TR202102255A2 TR 202102255 A2 TR202102255 A2 TR 202102255A2 TR 2021/002255 A TR2021/002255 A TR 2021/002255A TR 202102255 A TR202102255 A TR 202102255A TR 202102255 A2 TR202102255 A2 TR 202102255A2
Authority
TR
Turkey
Prior art keywords
virus
urine
analysis kit
detecting
urine analysis
Prior art date
Application number
TR2021/002255A
Other languages
Turkish (tr)
Inventor
Serhan Kurtulmuş Mehmet
Original Assignee
Mehmet Serhan Kurtulmus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mehmet Serhan Kurtulmus filed Critical Mehmet Serhan Kurtulmus
Priority to TR2021/002255A priority Critical patent/TR202102255A2/en
Publication of TR202102255A2 publication Critical patent/TR202102255A2/en
Priority to PCT/TR2021/050520 priority patent/WO2022177520A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/007—Devices for taking samples of body liquids for taking urine samples
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L1/00—Enclosures; Chambers
    • B01L1/52—Transportable laboratories; Field kits
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02—Adapting objects or devices to another
    • B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/02—Identification, exchange or storage of information
    • B01L2300/025—Displaying results or values with integrated means
    • B01L2300/028—Graduation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082—Test tubes per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus

Abstract

Buluş, Sars Cov-2 virüsü ve mutantları başta olmak üzere, viral hastalıkların tespit edilmesinde kullanılan, virüse ait protein, amino asit yapıların ve bunlara ait metabolitlerin idrarda tespit edilerek bir hastalığa ait klinik tablonun tespit edilebildiği bir idrar analiz kiti (10) ve kullanım yöntemi ile ilgilidir. Buluş özellikle, viral hastalıkların tespit edilmesinde virüse ait protein, amino asit yapıların ve bunlara ait metabolitlerin idrarda bir reaktan (30) kullanılarak tespit edilmesi, köpürtülmesi ve köpürtülen idrarın köpük seviyesine göre bireydeki virüsü ve virüs yoğunluğunu tespit eden bir idrar analiz kiti (10) ve kullanım yöntemi ile ilgilidir.The invention is a urine analysis kit (10) and its method of use, used in the detection of viral diseases, especially Sars Cov-2 virus and its mutants, in which the clinical picture of a disease can be detected by detecting the protein, amino acid structures of the virus and their metabolites in the urine. is about. In particular, the invention is a urine analysis kit (10) that detects the virus and virus density in the individual according to the foaming level of the foamed urine and detecting the protein, amino acid structures and their metabolites of the virus in the urine by using a reactant (30) in detecting viral diseases and regarding the method of use.

TR2021/002255A 2021-02-17 2021-02-17 URINE ANALYSIS KIT AND METHOD OF USE TR202102255A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2021/002255A TR202102255A2 (en) 2021-02-17 2021-02-17 URINE ANALYSIS KIT AND METHOD OF USE
PCT/TR2021/050520 WO2022177520A1 (en) 2021-02-17 2021-06-01 Urine test kit and how to use it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2021/002255A TR202102255A2 (en) 2021-02-17 2021-02-17 URINE ANALYSIS KIT AND METHOD OF USE

Publications (1)

Publication Number Publication Date
TR202102255A2 true TR202102255A2 (en) 2021-03-22

Family

ID=76373913

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2021/002255A TR202102255A2 (en) 2021-02-17 2021-02-17 URINE ANALYSIS KIT AND METHOD OF USE

Country Status (2)

Country Link
TR (1) TR202102255A2 (en)
WO (1) WO2022177520A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348207A (en) * 1981-01-29 1982-09-07 Cooper Laboratories, Inc. Method and means for determination of pregnancy
US10653911B1 (en) * 2019-08-14 2020-05-19 Phong Duy Bui System for liquid narcotic medication validation and deactivation
CN111999508A (en) * 2020-05-15 2020-11-27 上海交通大学 Diagnostic marker and application thereof in COVID-19 diagnosis and coronavirus past infection detection
CN111562367A (en) * 2020-06-15 2020-08-21 郑州方欣生物科技有限责任公司 Novel urine coronavirus rapid detection kit, preparation method and use method

Also Published As

Publication number Publication date
WO2022177520A1 (en) 2022-08-25

Similar Documents

Publication Publication Date Title
Keating et al. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women
Pawlotsky et al. Standardization of hepatitis C virus RNA quantification
Lanford et al. Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes
FI60720C (en) FOERFARANDE OCH MEDEL FOER BESTAEMNING AV AKTIVITETEN AV KREATINKINAS-MB
Bartolomé et al. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection
Ito et al. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection
BRPI0407299A (en) Methods for detecting an analyte associated with hiv, for determining the ratio of cd4+ t cells to cd8+ t cells, and for detecting hiv rna in a blood sample
Moodie et al. Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials
Kireev et al. Evaluating the accuracy and sensitivity of detecting minority HIV-1 populations by Illumina next-generation sequencing
TR202102255A2 (en) URINE ANALYSIS KIT AND METHOD OF USE
Johnston et al. Urine cell-free mitochondrial DNA as a marker of weight loss and body composition in older adults with HIV
KR890010562A (en) Active RNase L as a Marker of Virus Infection
Scordio et al. High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
MX2023000778A (en) Viral detection systems and uses thereof.
Henderson et al. Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcome
CN105209048A (en) Methods for determining viral sensitivity to viral inhibitors
ENDO et al. Microbial biosensor system for rapid determination of vitamin B6
Coquet Factoring in CD4 T cells during treatment of HIV
Kumar et al. Standardization and validation of Vero cell assay for potency estimation of diphtheria antitoxin serum
CN110382713A (en) Improved epigenetic immunocytochemistry method
FI961678A0 (en) Primers and probes for amplification and detection of CMV nucleic acid
WO2016021719A1 (en) Mood disorder marker, application therefor, schizophrenia marker, and application therefor
CN215339899U (en) Protein chip and kit for detecting novel coronavirus S antigen
DK1282822T3 (en) Methods and compositions for detecting larval stage Taenia solium with a cloned diagnostic antigen
Kondrateva et al. PO. 3.65 The leptin and adiponectin levels in patients with systemic lupus erythematosus and their relationship with cardiovascular risk factors